Arkolith/Insider Trading/AEON/Form 4

Oh Chad

CHIEF MEDICAL OFFICERAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Mar 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Grant(A)1.3M—$02.2M
Feb 17, 2026Grant(A)863K—$0867K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-026550) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML